[Corrections] Correction to Lancet Oncol 2020; 21: 645–54

Trigo J, Subbiah V, Besse B, et al. Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial. Lancet Oncol 2020; 21: 645–54—In this Article, Prof Armando Santoro’s affiliation details were wrong and have been corrected. This correction has been made to the online version as of Nov 30, 2020.

Lascia un commento